ACTRIMS: Americas Committee for Treatment and Research in Multiple Sclerosis
Conference Coverage
Brain atrophy may be a clinically relevant measure in PPMS: Data from INFORMS
Key clinical point: Brain atrophy could be a clinically useful and relevant measure in primary progressing multiple sclerosis.
Conference Coverage
Triage MS-related ED visits to reduce unnecessary treatment
The majority of multiple sclerosis–related emergency department visits in a recent chart review were related to pseudoflares or MS-related...
Conference Coverage
Fingolimod improved gait impairment in small study
Key clinical point: Fingolimod shows signs that it may improve gait in MS patients who are naive to treatment or have only received first-line...
Conference Coverage
VIDEO: Novel tools measure disease progression in MS
The visual system is relevant and accessible for the study of multiple sclerosis and can aid in the measurement of neuronal and axonal injury.
Conference Coverage
Positive headway reported for progressive multiple sclerosis
Conference Coverage
VIDEO: MS stem cell therapy research progresses, including oligodendrocyte progenitor trial
Stem cell therapy for progressive multiple sclerosis is an intriguing and controversial topic, and the state of the related science was addressed...
Conference Coverage
Ocrelizumab subanalysis hints at better efficacy with active inflammatory lesions
Key clinical point: Certain subgroups of patients may respond better to treatment Major finding: Reduction in the risk of confirmed disability...
Conference Coverage
Blood-borne biomarkers of MS relapse identified
Key clinical point: Blood-borne biomarkers of MS relapse and treatment efficacy were identified. Major finding: RGC-32, FasL, and IL-21 are...
Conference Coverage
Treatment justified even for moderately advanced MS disability
Treatment for MS should continue even when disability is advanced.
Conference Coverage
Potential biomarkers of gray matter damage in MS identified
The pattern of the CSF biomarkers, which correspond to the extent of gray matter damage, has potential value in stratifying patients in terms of...
Conference Coverage
VIDEO: Progressive MS trial failures provide lessons for future success
Findings last year from the ORATORIO trial showed for the first time that a pharmaceutical agent – ocrelizumab – was effective for slowing the...
Conference Coverage
VIDEO: Bench research provides insight into progressive MS
A “Lessons from the Bench” session at the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2016 addressed the...
Conference Coverage
ACTRIMS: Ovarian decline linked to MS progression in women
Key clinical point: Anti-m<scaps>ü</scaps>llerian hormone may be a biologic marker of MS progression in women.
Conference Coverage
ACTRIMS: Treadmill exercise transiently benefits cognition in MS patients
Treadmill exercise can at least transiently improve cognitive impairment in patients with multiple sclerosis.
Conference Coverage
VIDEO: ACTRIMS Forum focuses on progressive MS
A focus of the 2016 Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum is the pathogenic mechanisms involved in...